Nemaura Medical is a medical devices business based in the US. Nemaura Medical shares (NMRD) are listed on the PINK and all prices are listed in US Dollars. Its last market close was $0.00 – the same closing value as a week prior. Nemaura Medical employs 36 staff and has a market cap (total outstanding shares value) of 0.00.
The Finder Score crunches 147 key metrics we collected directly from 18+ brokers and assessed each provider’s performance based on nine different categories, weighing each metric based on the expertise and insights of Finder’s investment experts. We then scored and ranked each provider to determine the best brokerage accounts.
We update our best picks as products change, disappear or emerge in the market. We also regularly review and revise our selections to ensure our best provider lists reflect the most competitive available.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $0.00 |
|---|---|
| 52-week range | $0.00 - $0.06 |
| 50-day moving average | $0.00 |
| 200-day moving average | $0.01 |
| Wall St. target price | $1.50 |
| PE ratio | N/A |
| Dividend yield | N/A |
| Earnings per share (TTM) | $-0.39 |
Historical closes compared with the close of $0.0001 from 2025-05-02
| 1 week (2025-04-28) | -50.00% |
|---|---|
| 1 month (2025-04-04) | -50.00% |
| 3 months (2025-02-06) | 0.0001 |
| 6 months (2024-11-06) | -50.00% |
| 1 year (2024-05-06) | -99.67% |
|---|---|
| 2 years (2023-05-05) | -99.99% |
| 3 years (2022-05-05) | 3.6699 |
| 5 years (2020-05-05) | 5.23 |
| Gross profit TTM | $-1,478,109 |
|---|---|
| Return on assets TTM | -81.19% |
| Return on equity TTM | -724.44% |
| Profit margin | 0% |
| Book value | $-0.62 |
| Market Capitalization | $4,035 |
TTM: trailing 12 months
We're not expecting Nemaura Medical to pay a dividend over the next 12 months.
Nemaura Medical's shares were split on a 1:10 basis on 4 December 2019 . So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Nemaura Medical shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for Nemaura Medical shares which in turn could have impacted Nemaura Medical's share price.
Over the last 12 months, Nemaura Medical's shares have ranged in value from as little as $0.0001 up to $0.064. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (PINK average) beta is 1, while Nemaura Medical's is -100.9. This would suggest that Nemaura Medical's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Nemaura Medical has bucked the trend.
Nemaura Medical Inc. , a medical technology company, manufactures continuous glucose monitoring system in the United States. It offers sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company also offers proBEAT, a wellness guidance notes, that provide prompts and educate users on factors affecting blood sugar profiles, as well as conducts diabetes prevention and reversal programs. Nemaura Medical Inc. was founded in 2009 and is based in New York, New York. .
Some of the best paper trading apps to practice stock trading with fake money include Interactive Brokers, eToro, Charles Schwab and more.
These are the stocks to buy when you don’t have much to spend.
These are the best day trading apps, according to Finder’s comprehensive analysis.
Explore the best bonuses for opening a new brokerage account.
Some of the best stock trading apps for beginners include SoFi, Robinhood, Public, Stash, Opto and more. Compare your options here.
Want to buy and sell international stocks? Here are the top brokers to help you trade global markets.
These are the best discount brokers of 2025 according to Finder’s comprehensive review.
Compare the 7 best stock picking services, according to Finder’s analysis, and learn how to choose the best option for your needs.
Check out our picks of the best trading apps for beginners, options traders, hands-off investors and more.
See our picks of the best brokerage accounts, including Fidelity, SoFi, Charles Schwab, Public, Robinhood and E*TRADE .